Biovista is a company that provides drug repositioning and de-risking clinical solutions for the biopharma industry. It offers the Project Prodigy platform that enables augmented intelligence, natural language processing, graph databases that support discovery and knowledge analytics, and AI Health Shield for medicine decision support. The company also provides mechanism-of-action modeling, risk assessment, and oncology services.